Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewgenij Proschak

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Molecules (Basel, Switzerland)|February 25, 2022
Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective PropertiesMargherita Mastromarino, Mauro Niso, Carmen Abate, et al.
Plos Computational Biology|February 24, 2012
DOGS: reaction-driven de novo design of bioactive compoundsMarkus Hartenfeller, Heiko Zettl, Miriam Walter, et al.
Journal of Medicinal Chemistry|December 23, 2009
Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocolFlorian Rörsch, Ivonne Wobst, Heiko Zettl, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Analytical Biochemistry|February 8, 2018
A coupled fluorescence-based assay for the detection of protein arginine N-methyltransferase 6 (PRMT6) enzymatic activityJan Kramer, Veronika Désor, Steffen Brunst, et al.
Bioorganic & Medicinal Chemistry|October 13, 2016
Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitorsStefanie Hauck, Kerstin Hiesinger, Sabrina Khageh Hosseini, et al.
Diabetologia|July 23, 2018
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetesMd Abdul Hye Khan, Lauren Kolb, Melissa Skibba, et al.
Scientific Reports|September 12, 2018
Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitroPascal Heitel, Leonie Gellrich, Jan Heering, et al.
Journal of Medicinal Chemistry|November 8, 2012
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptorsEstel la Buscató, René Blöcher, Christina Lamers, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2008
Structure-based pharmacophore screening for natural-product-derived PPARgamma agonistsYusuf Tanrikulu, Oliver Rau, Oliver Schwarz, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Molecules (Basel, Switzerland)|February 25, 2022
Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective PropertiesMargherita Mastromarino, Mauro Niso, Carmen Abate, et al.
Plos Computational Biology|February 24, 2012
DOGS: reaction-driven de novo design of bioactive compoundsMarkus Hartenfeller, Heiko Zettl, Miriam Walter, et al.
Journal of Medicinal Chemistry|December 23, 2009
Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocolFlorian Rörsch, Ivonne Wobst, Heiko Zettl, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Analytical Biochemistry|February 8, 2018
A coupled fluorescence-based assay for the detection of protein arginine N-methyltransferase 6 (PRMT6) enzymatic activityJan Kramer, Veronika Désor, Steffen Brunst, et al.
Bioorganic & Medicinal Chemistry|October 13, 2016
Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitorsStefanie Hauck, Kerstin Hiesinger, Sabrina Khageh Hosseini, et al.
Diabetologia|July 23, 2018
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetesMd Abdul Hye Khan, Lauren Kolb, Melissa Skibba, et al.
Scientific Reports|September 12, 2018
Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitroPascal Heitel, Leonie Gellrich, Jan Heering, et al.
Journal of Medicinal Chemistry|November 8, 2012
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptorsEstel la Buscató, René Blöcher, Christina Lamers, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2008
Structure-based pharmacophore screening for natural-product-derived PPARgamma agonistsYusuf Tanrikulu, Oliver Rau, Oliver Schwarz, et al.
Pageof 19